{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:54:49Z","timestamp":1776725689355,"version":"3.51.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shaanxi Provincial People's Hospital incubation Fund","award":["2022YJY-13"],"award-info":[{"award-number":["2022YJY-13"]}]},{"name":"Shaanxi Provincial People's Hospital Science and technology talent support plan","award":["2021JY-43"],"award-info":[{"award-number":["2021JY-43"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14610-1","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:09:18Z","timestamp":1753920558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combination of PI-RADS version 2.1 and amide proton transfer values for the detection of clinically significant prostate cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"14610_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics. CA Cancer J Clin. 2022;72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"key":"14610_CR2","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Prostate Cancer. Version 3.2020. Fort Washington: National Comprehensive Cancer Network; 2020."},{"key":"14610_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"14610_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","volume":"17","author":"JL Mohler","year":"2019","unstructured":"Mohler JL, Antonarakis ES, Armstrong AJ, et al. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(5):479\u2013505. https:\/\/doi.org\/10.6004\/jnccn.2019.0023.","journal-title":"J Natl Compr Canc Netw"},{"key":"14610_CR5","unstructured":"PI-RADs https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/PI-RADS."},{"key":"14610_CR6","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1464-410X.2010.09808.x","volume":"107","author":"NB Delongchamps","year":"2011","unstructured":"Delongchamps NB, Rouanne M, Flam T, Beuvon F, Liberatore M, Zerbib M, et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int. 2011;107:1411\u20138. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09808.x.","journal-title":"BJU Int"},{"key":"14610_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","volume":"76","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol. 2019;76:340\u201351. https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033.","journal-title":"Eur Urol"},{"key":"14610_CR8","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.3390\/curroncol29090502","volume":"29","author":"J Liu","year":"2022","unstructured":"Liu J, Pan S, Dong L, Wu G, Wang J, Wang Y, et al. The diagnostic value of PI-RADS v2.1 in patients with a history of transurethral resection of the prostate (TURP). Curr Oncol. 2022;29:6373\u201382. https:\/\/doi.org\/10.3390\/curroncol29090502.","journal-title":"Curr Oncol"},{"key":"14610_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/RCT.0000000000001313","volume":"46","author":"N Kim","year":"2022","unstructured":"Kim N, Kim S, Prabhu V, Shanbhogue K, Smereka P, Tong A, et al. Comparison of prostate imaging and reporting data system V2.0 and V2.1 for evaluation of transition zone lesions: a 5-reader 202-patient analysis. J Comput Assist Tomogr. 2022;46:523\u20139. https:\/\/doi.org\/10.1097\/RCT.0000000000001313.","journal-title":"J Comput Assist Tomogr"},{"key":"14610_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.juro.2017.09.074","volume":"199","author":"T Ullrich","year":"2018","unstructured":"Ullrich T, Quentin M, Arsov C, Schmaltz AK, Tschischka A, Laqua N, et al. Risk stratification of equivocal lesions on multiparametric magnetic resonance imaging of the prostate. J Urol. 2018;199:691\u20138. https:\/\/doi.org\/10.1016\/j.juro.2017.09.074.","journal-title":"J Urol"},{"key":"14610_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.euf.2019.06.014","volume":"6","author":"M Maggi","year":"2020","unstructured":"Maggi M, Panebianco V, Mosca A, Salciccia S, Gentilucci A, Di Pierro G, et al. Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus. 2020;6:463\u201378. https:\/\/doi.org\/10.1016\/j.euf.2019.06.014.","journal-title":"Eur Urol Focus"},{"key":"14610_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.961985","volume":"12","author":"D Singh","year":"2022","unstructured":"Singh D, Kumar V, Das CJ, Singh A, Mehndiratta A. Machine learning-based analysis of a semi-automated PI-RADS v2.1 scoring for prostate cancer. Front Oncol. 2022;12: 961985. https:\/\/doi.org\/10.3389\/fonc.2022.961985.","journal-title":"Front Oncol"},{"key":"14610_CR13","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1007\/s00330-020-06884-9","volume":"30","author":"N Meng","year":"2020","unstructured":"Meng N, Wang X, Sun J, Han D, Ma X, Wang K, et al. Application of the amide proton transfer-weighted imaging and diffusion kurtosis imaging in the study of cervical cancer. Eur Radiol. 2020;30:5758\u201367. https:\/\/doi.org\/10.1007\/s00330-020-06884-9.","journal-title":"Eur Radiol"},{"key":"14610_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109047","volume":"129","author":"T Kamitani","year":"2020","unstructured":"Kamitani T, Sagiyama K, Togao O, Yamasaki Y, Hida T, Matsuura Y, et al. Amide proton transfer (APT) imaging of parotid tumors: differentiation of malignant and benign tumors. Eur J Radiol. 2020;129: 109047 https:\/\/doi.org\/10.1016\/j.ejrad.2020.109047.","journal-title":"Eur J Radiol"},{"key":"14610_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40644-022-00515-w","volume":"23","author":"L Yang","year":"2023","unstructured":"Yang L, Wang L, Tan Y, Dan H, Xian P, Zhang Y, et al. Amide proton transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study. Cancer Imaging. 2023;23:3. https:\/\/doi.org\/10.1186\/s40644-022-00515-w.","journal-title":"Cancer Imaging"},{"key":"14610_CR16","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jmri.28204","volume":"56","author":"Z Guo","year":"2022","unstructured":"Guo Z, Qin X, Mu R, Lv J, Meng Z, Zheng W, et al. Amide proton transfer could provide more accurate lesion characterization in the transition zone of the prostate. J Magn Reson Imaging. 2022;56:1311\u20139. https:\/\/doi.org\/10.1002\/jmri.28204.","journal-title":"J Magn Reson Imaging"},{"key":"14610_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.640906","volume":"11","author":"H Yin","year":"2021","unstructured":"Yin H, Wang D, Yan R, Jin X, Hu Y, Zhai Z, et al. Comparison of diffusion kurtosis imaging and amide proton transfer imaging in the diagnosis and risk assessment of prostate cancer. Front Oncol. 2021;11: 640906. https:\/\/doi.org\/10.3389\/fonc.2021.640906.","journal-title":"Front Oncol"},{"key":"14610_CR18","doi-asserted-by":"publisher","first-page":"812","DOI":"10.21037\/qims-22-721","volume":"13","author":"X Qin","year":"2023","unstructured":"Qin X, Mu R, Zheng W, Li X, Liu F, Zhuang Z, et al. Comparison and combination of amide proton transfer magnetic resonance imaging and the apparent diffusion coefficient in differentiating the grades of prostate cancer. Quant Imaging Med Surg. 2023;13:812\u201324. https:\/\/doi.org\/10.21037\/qims-22-721.","journal-title":"Quant Imaging Med Surg"},{"key":"14610_CR19","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00261-023-03929-7","volume":"48","author":"R Nicola","year":"2023","unstructured":"Nicola R, Bittencourt LK. PI-RADS 3 lesions: a critical review and discussion of how to improve management. Abdom Radiol (NY). 2023;48:2401\u20135. https:\/\/doi.org\/10.1007\/s00261-023-03929-7.","journal-title":"Abdom Radiol (NY)"},{"key":"14610_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41391-019-0155-0","volume":"23","author":"Z Lv","year":"2020","unstructured":"Lv Z, Jiang H, Hu X, Yang C, Chand H, Tang C, et al. Efficacy and safety of periprostatic nerve block combined with perineal subcutaneous anaesthesia and intrarectal lidocaine gel in transrectal ultrasound guided transperineal prostate biopsy: a prospective randomised controlled trial. Prostate Cancer Prostatic Dis. 2020;23:74\u201380. https:\/\/doi.org\/10.1038\/s41391-019-0155-0.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"14610_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00292-015-0136-6","volume":"37","author":"G Kristiansen","year":"2016","unstructured":"Kristiansen G, Egevad L, Amin M, et al. Konsenskonferenz 2014 der ISUP zur Gleason-Graduierung des Prostatakarzinoms [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma]. Pathologe. 2016;37:17\u201326. https:\/\/doi.org\/10.1007\/s00292-015-0136-6.","journal-title":"Pathologe"},{"key":"14610_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/jmri.24994","volume":"43","author":"S Ahlawat","year":"2016","unstructured":"Ahlawat S, Khandheria P, Del Grande F, Morelli J, Subhawong TK, Demehri S, et al. Interobserver variability of selective region-of-interest measurement protocols for quantitative diffusion weighted imaging in soft tissue masses: comparison with whole tumor volume measurements. J Magn Reson Imaging. 2016;43:446\u201354. https:\/\/doi.org\/10.1002\/jmri.24994.","journal-title":"J Magn Reson Imaging"},{"key":"14610_CR23","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3348\/kjr.2020.0837","volume":"22","author":"HS Kim","year":"2021","unstructured":"Kim HS, Kwon GY, Kim MJ, Park SY. Prostate imaging-reporting and data system: comparison of the diagnostic performance between version 2.0 and 2.1 for prostatic peripheral zone. Korean J Radiol. 2021;22:1100\u20139. https:\/\/doi.org\/10.3348\/kjr.2020.0837.","journal-title":"Korean J Radiol"},{"key":"14610_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72544-z","volume":"10","author":"MM Rudolph","year":"2020","unstructured":"Rudolph MM, Baur ADJ, Cash H, Haas M, Mahjoub S, Hartenstein A, et al. Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer. Sci Rep. 2020;10: 15982. https:\/\/doi.org\/10.1038\/s41598-020-72544-z.","journal-title":"Sci Rep"},{"key":"14610_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-022-00515-w","volume":"23","author":"L Yang","year":"2023","unstructured":"Yang L, Wang L, Tan Y, Dan H, Xian P, Zhang Y, et al. Amide proton transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study. Cancer Imaging. 2023;23: 3. https:\/\/doi.org\/10.1186\/s40644-022-00515-w.","journal-title":"Cancer Imaging"},{"key":"14610_CR26","doi-asserted-by":"publisher","unstructured":"Qin X, Mu R, Zheng W, Li X, Liu F, Zhuang Z, et al. Comparison and combination of amide proton transfer magnetic resonance imaging and the apparent diffusion coefficient in differentiating the grades of prostate cancer. Quantitative Imaging In Medicine And Surgery.2022;13, 812\u2013824.https:\/\/doi.org\/10.21037\/qims-22-721.","DOI":"10.21037\/qims-22-721"},{"key":"14610_CR27","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/jmri.22480","volume":"33","author":"G Jia","year":"2011","unstructured":"Jia G, Abaza R, Williams JD, Zynger DL, Zhou J, Shah ZK, et al. Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging. 2011;33:647\u201354. https:\/\/doi.org\/10.1002\/jmri.22480.","journal-title":"J Magn Reson Imaging"},{"key":"14610_CR28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s10334-016-0537-4","volume":"29","author":"Y Takayama","year":"2016","unstructured":"Takayama Y, Nishie A, Sugimoto M, Togao O, Asayama Y, Ishigami K, et al. Amide proton transfer (APT) magnetic resonance imaging of prostate cancer: comparison with Gleason scores. MAGMA. 2016;29:671\u20139. https:\/\/doi.org\/10.1007\/s10334-016-0537-4.","journal-title":"MAGMA"},{"key":"14610_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.21037\/tau.2017.12.31","volume":"7","author":"IG Schoots","year":"2018","unstructured":"Schoots IG. MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? Transl Androl Urol. 2018;7:70\u201382. https:\/\/doi.org\/10.21037\/tau.2017.12.31.","journal-title":"Transl Androl Urol"},{"key":"14610_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/neuonc\/not158","volume":"16","author":"O Togao","year":"2014","unstructured":"Togao O, Yoshiura T, Keupp J, et al. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol. 2014;16:441\u20138.","journal-title":"Neuro Oncol"},{"key":"14610_CR31","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1007\/s00330-020-07397-1","volume":"31","author":"W Chen","year":"2021","unstructured":"Chen W, Li L, Yan Z, Hu S, Feng J, Liu G, et al. Three-dimension amide proton transfer MRI of rectal adenocarcinoma: correlation with pathologic prognostic factors and comparison with diffusion kurtosis imaging. Eur Radiol. 2021;31:3286\u201396. https:\/\/doi.org\/10.1007\/s00330-020-07397-1.","journal-title":"Eur Radiol"},{"key":"14610_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1148\/radiol.211804","volume":"305","author":"HJ Wang","year":"2022","unstructured":"Wang HJ, Cai Q, Huang YP, Li MQ, Wen ZH, Lin YY, et al. Amide proton transfer-weighted MRI in predicting histologic grade of bladder cancer. Radiology. 2022;305:127\u201334. https:\/\/doi.org\/10.1148\/radiol.211804.","journal-title":"Radiology"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14610-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14610-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14610-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:18:42Z","timestamp":1757319522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14610-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14610"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14610-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4168033\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Shaanxi Provincial People's Hospital, and all subjects signed an informed consent form before the examination, and all methods were carried out in accordance with relevant guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1249"}}